Literature DB >> 26760521

Approach to asymptomatic creatine kinase elevation.

Siamak Moghadam-Kia1,2, Chester V Oddis1, Rohit Aggarwal3.   

Abstract

How to manage a patient who has an elevated serum creatine kinase (CK) level but no or insignificant muscle-related signs and symptoms is a clinical conundrum. The authors provide a systematic approach, including repeat testing after a period of rest, defining higher thresholds over which pursuing a diagnosis is worthwhile, and evaluating for a variety of nonneuromuscular causes. They also outline a workup for neuromuscular causes.
Copyright © 2016 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26760521      PMCID: PMC4871266          DOI: 10.3949/ccjm.83a.14120

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  36 in total

Review 1.  Safety issues with statin therapy.

Authors:  Robert L Talbert
Journal:  J Am Pharm Assoc (2003)       Date:  2006 Jul-Aug

2.  Acute exertional rhabdomyolysis in hypothyroidism: the result of a reversible defect in glycogenolysis?

Authors:  J E Riggs
Journal:  Mil Med       Date:  1990-04       Impact factor: 1.437

3.  Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.

Authors:  M R Weglinski; D J Wedel; A G Engel
Journal:  Anesth Analg       Date:  1997-05       Impact factor: 5.108

4.  Persistent hyperCKemia: fourteen patients studied in retrospect.

Authors:  L M Brewster; M de Visser
Journal:  Acta Neurol Scand       Date:  1988-01       Impact factor: 3.209

5.  Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study.

Authors:  R F Duyff; J Van den Bosch; D M Laman; B J van Loon; W H Linssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

6.  Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia.

Authors:  L M Prisant; M Downton; L O Watkins; H Schnaper; R H Bradford; A N Chremos; A Langendörfer
Journal:  Am J Cardiol       Date:  1996-08-15       Impact factor: 2.778

7.  EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia.

Authors:  T Kyriakides; C Angelini; J Schaefer; S Sacconi; G Siciliano; J J Vilchez; D Hilton-Jones
Journal:  Eur J Neurol       Date:  2010-04-05       Impact factor: 6.089

8.  Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study.

Authors:  Hallvard Lilleng; Karin Abeler; Stein H Johnsen; Eva Stensland; Sissel Løseth; Rolf Jorde; Yngve Figenschau; Sigurd Lindal; Tom Wilsgaard; Svein I Bekkelund
Journal:  Neuromuscul Disord       Date:  2011-05-17       Impact factor: 4.296

9.  A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.

Authors:  Ery Kus Dwianingsih; Yasuhiro Takeshima; Kyoko Itoh; Yumiko Yamauchi; Hiroyuki Awano; Rusdy Ghazali Malueka; Atsushi Nishida; Mitsunori Ota; Mariko Yagi; Masafumi Matsuo
Journal:  Mol Genet Metab       Date:  2010-07-01       Impact factor: 4.797

10.  Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study.

Authors:  J L Joy; S J Oh
Journal:  Muscle Nerve       Date:  1989-03       Impact factor: 3.217

View more
  28 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Regionally Impaired Redox Homeostasis in the Brain of Rats Subjected to Global Perinatal Asphyxia: Sustained Effect up to 14 Postnatal Days.

Authors:  Carolyne Lespay-Rebolledo; Ronald Perez-Lobos; Andrea Tapia-Bustos; Valentina Vio; Paola Morales; Mario Herrera-Marschitz
Journal:  Neurotox Res       Date:  2018-06-29       Impact factor: 3.911

3.  Cabozantinib-induced serum creatine kinase elevation and musculoskeletal complaints.

Authors:  Sarah E Stump; Young E Whang; Daniel J Crona
Journal:  Invest New Drugs       Date:  2018-06-28       Impact factor: 3.850

4.  Investigation of the Effect of Atorvastatin on Skeletal Muscles in Male Rats and the Involved Mechanisms.

Authors:  K M Hassani
Journal:  Arch Razi Inst       Date:  2022-02-28

5.  Molecular characterization and reclassification of a 1.18 Mbp DMD duplication following positive carrier screening for Duchenne/Becker muscular dystrophy.

Authors:  Cinthya J Zepeda-Mendoza; Jordan E Bontrager; Camille F Fisher; Amber McDonald; Jaya K George-Abraham; Linda Hasadsri
Journal:  Clin Case Rep       Date:  2022-07-11

6.  Fis1 deficiencies differentially affect mitochondrial quality in skeletal muscle.

Authors:  Zhe Zhang; Danielle A Sliter; Christopher K E Bleck; Shuzhe Ding
Journal:  Mitochondrion       Date:  2019-09-14       Impact factor: 4.160

7.  Dynamic transcriptomic analysis of Ischemic Injury in a Porcine Pre-Clinical Model mimicking Donors Deceased after Circulatory Death.

Authors:  Sebastien Giraud; Clara Steichen; Geraldine Allain; Pierre Couturier; Delphine Labourdette; Sophie Lamarre; Virginie Ameteau; Solenne Tillet; Patrick Hannaert; Raphael Thuillier; Thierry Hauet
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

8.  Remission of aggressive autoimmune disease (dermatomyositis) with removal of infective jaw pathology and ozone therapy: review and case report.

Authors:  Robert Jay Rowen
Journal:  Auto Immun Highlights       Date:  2018-06-30

9.  Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.

Authors:  Remo Panaccione; John D Isaacs; Lea Ann Chen; Wenjin Wang; Amy Marren; Kenneth Kwok; Lisy Wang; Gary Chan; Chinyu Su
Journal:  Dig Dis Sci       Date:  2020-08-20       Impact factor: 3.199

10.  Ratio of Creatine Kinase to Alanine Aminotransferase as a Biomarker of Acute Liver Injury in Dystrophinopathy.

Authors:  Liang Wang; Menglong Chen; Min Xu; Jing Li; Pinning Feng; Ruojie He; Yuling Zhu; Huan Li; Jinfu Lin; Cheng Zhang
Journal:  Dis Markers       Date:  2018-06-19       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.